Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1993-09-13
1994-10-25
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
544220, C07D40310, A61K 3153
Patent
active
053589475
ABSTRACT:
The invention provides novel 2,3-substituted pyrazolo[1,5-a]-1,3,5-triazin-4(3H)-ones having the formula: ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are described in the specification which have activity as angiotensin II (AII) antagonists.
REFERENCES:
patent: 5162340 (1992-11-01), Chakravartz
patent: 5202320 (1993-04-01), Tidwell et al.
patent: 5217973 (1993-06-01), Bru-Magniez
patent: 5223501 (1993-06-01), Chakravartz
patent: 5231094 (1993-07-01), Bau-Magniez
patent: 5260285 (1993-11-01), Allen
Kim, Chemical Abstracts, vol. 106, entry 102327m (1987).
American Cyanamid Company
Ford John M.
Szatkowski Thomas S.
LandOfFree
Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a] does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a], we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3-substituted pyrazolo[1,5-a] will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-135561